These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34401593)

  • 1. Cardiovascular risk assessment among type-2 diabetic subjects in selected areas of Bangladesh: concordance among without cholesterol-based WHO/ISH, Globorisk, and Framingham risk prediction tools.
    Mondal R; Ritu RB; Banik PC
    Heliyon; 2021 Aug; 7(8):e07728. PubMed ID: 34401593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordance between two versions of world health organization/international society of hypertension risk prediction chart and framingham risk score among postmenopausal women in a rural area of Bangladesh.
    Barua L; Faruque M; Banik PC; Ali L
    Indian J Public Health; 2019; 63(2):101-106. PubMed ID: 31219057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agreement between ten-years cardiovascular disease risk assessment tools: An application to Iranian population in Shahedieh Cohort Study.
    Momayyezi M; Sefidkar R; Fallahzadeh H
    Heliyon; 2023 Oct; 9(10):e20396. PubMed ID: 37810856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Assessment for Cardiovascular Disease Using the Framingham Risk Score and Globorisk Score Among Newly Diagnosed Metabolic Syndrome Patients.
    Adil SO; Uddin F; Musa KI; Khan A; Shakeel A; Shafique K; Islam MA
    Int J Gen Med; 2023; 16():4295-4305. PubMed ID: 37753441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Place of cardiovascular risk prediction models in South Asians; agreement between Framingham risk score and WHO/ISH risk charts.
    Mettananda KCD; Gunasekara N; Thampoe R; Madurangi S; Pathmeswaran A
    Int J Clin Pract; 2021 Jul; 75(7):e14190. PubMed ID: 33780102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Framingham Risk Scores of Patients with Type 2 Diabetes Mellitus in the Beijing Community: A 10-Year Prospective Study of the Effects of Multifactorial Interventions on Cardiovascular Risk Factors (The Beijing Communities Diabetes Study 22).
    Zhang XL; Wan G; Yuan MX; Yang GR; Fu HJ; Zhu LX; Xie RR; Lv YJ; Zhang JD; Li YL; Dai QF; Ji Y; Holman RR; Yuan SY;
    Diabetes Ther; 2020 Apr; 11(4):885-903. PubMed ID: 32086768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk assessment in type 2 diabetes mellitus: comparison of the World Health Organization/International Society of Hypertension risk prediction charts versus UK Prospective Diabetes Study risk engine.
    Herath HM; Weerarathna TP; Umesha D
    Vasc Health Risk Manag; 2015; 11():583-9. PubMed ID: 26622181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of two versions of the WHO/international society of hypertension absolute cardiovascular risk assessment tools in a rural Bangladeshi population.
    Fatema K; Zwar NA; Milton AH; Rahman B; Ali L
    BMJ Open; 2015 Oct; 5(10):e008140. PubMed ID: 26463220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambiguity about Selection of Cardiovascular Risk Stratification Tools: Evidence from a North Indian Rural Population.
    Singh T; Pilania M; Jat GS; Kumar R
    Indian J Community Med; 2018; 43(3):170-174. PubMed ID: 30294082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 3 risk estimators to guide initiation of statin therapy for primary prevention of cardiovascular disease.
    Ofori S; Dodiyi-Manuel S; Akpa MR
    J Clin Lipidol; 2017; 11(6):1441-1447. PubMed ID: 29050979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative assessment between Globorisk and WHO cardiovascular disease risk scores: a population-based study.
    Dehghan A; Rezaei F; Aune D
    Sci Rep; 2023 Aug; 13(1):14229. PubMed ID: 37648706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory-based and office-based Globorisk scores to predict 10-year risk of cardiovascular diseases among Iranians: results from the Fasa PERSIAN cohort.
    Jahangiry L; Dehghan A; Farjam M; Aune D; Rezaei F
    BMC Med Res Methodol; 2022 Nov; 22(1):305. PubMed ID: 36435774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian population.
    Selvarajah S; Kaur G; Haniff J; Cheong KC; Hiong TG; van der Graaf Y; Bots ML
    Int J Cardiol; 2014 Sep; 176(1):211-8. PubMed ID: 25070380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran.
    Fahimfar N; Fotouhi A; Mansournia MA; Malekzadeh R; Sarrafzadegan N; Azizi F; Mansourian M; Sepanlou SG; Emamian MH; Hadaegh F; Roohafza H; Hashemi H; Poustchi H; Pourshams A; Samavat T; Sharafkhah M; Talaei M; Van Klaveren D; Steyerberg EW; Khalili D
    Int J Health Policy Manag; 2022 Feb; 11(2):210-217. PubMed ID: 32668896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of cardiovascular risk in a rural population of Lucknow district using WHO/ISH risk prediction charts.
    Deori TJ; Agarwal M; Masood J; Sharma S; Ansari A
    J Family Med Prim Care; 2020 Sep; 9(9):4853-4860. PubMed ID: 33209812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus.
    Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
    Eur J Prev Cardiol; 2021 Apr; 28(3):346-352. PubMed ID: 33891687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographic and Sociodemographic Disparities in Cardiovascular Risk in Burkina Faso: Findings from a Nationwide Cross-Sectional Survey.
    Cisse K; Samadoulougou S; Ouedraogo M; Bonnechère B; Degryse JM; Kouanda S; Kirakoya-Samadoulougou F
    Risk Manag Healthc Policy; 2021; 14():2863-2876. PubMed ID: 34262373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Inverse Association between Framingham Risk Score and Estimated Glomerular Filtration Rate in Moderate to Severe Diabetic Kidney Disease.
    Khaloo P; Alemi H; Mansournia MA; Rabizadeh S; Salehi SS; Blaha MJ; Mirbolouk MH; Mirmiranpour H; Esteghamati A; Nakhjavani M
    Arch Iran Med; 2019 Feb; 22(2):91-98. PubMed ID: 30980645
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.